» Articles » PMID: 30463909

The Role of Chamaejasmine in Cellular Apoptosis and Autophagy in MG-63 Cells

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2018 Nov 23
PMID 30463909
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Osteosarcoma (OS) is the most common malignant neoplasm in children and adolescents with a very high propensity for local invasion and poor response to current therapy. Anti-cancer effect of chamaejasmine is newly discovered from Stellera chamaejasmine L. Our study focuses on investigating the effect of chamaejasmine on the cellular apoptosis, proliferation, autophagy, and the underlying mechanisms in MG-63.

Methods: Our study investigated the concentration of chamaejasmine in MG-63 cells by MTT and verified that chamaejasmine inhibited cell invasion by transwell. We also used Hoechst staining as well as apoptotic associated-proteins in MG-63 cells. Meanwhile, we also detected the lysophagesome and autophagsome by Lysotracker. Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) knockdown was performed with siRNA.

Results: Our results show that chamaejasmine exerts cellular growth inhibition, pro-apoptotic and pro-autophagic effect via activating AMPK in MG-63 cells. Furthermore, chamaejasmine significantly increases autophagic cell via the inhibition of mammalian target of rapamycin (mTOR) and activation of AMPK signaling pathways. Administrated with chamaejasmine also induces reactive oxygen species (ROS) generation, indicating cross-talking between these two primary modes of programmed cell death.

Conclusion: Our results show that chamaejasmine promotes apoptosis and autophagy by activating AMPK/mTOR signaling pathways with involvement of ROS in MG-63 cells. Chamaejasmine is a promising anti-cancer agent in OS treatment, and further studies are needed to confirm its efficacy and safety or other cancer cells.

Citing Articles

Isocorydine Exerts Anticancer Activity by Disrupting the Energy Metabolism and Filamentous Actin Structures of Oral Squamous Carcinoma Cells.

Zhou Q, Zhang Q, Liao L, Li Q, Qu H, Wang X Curr Issues Mol Biol. 2024; 46(1):650-662.

PMID: 38248344 PMC: 10814041. DOI: 10.3390/cimb46010042.


Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma.

Liao Y, Yu H, Lv J, Cai Y, Liu F, He Z Int J Oncol. 2019; 55(6):1213-1222.

PMID: 31638211 PMC: 6831203. DOI: 10.3892/ijo.2019.4902.


Short Overview of ROS as Cell Function Regulators and Their Implications in Therapy Concepts.

Milkovic L, cipak Gasparovic A, Cindric M, Mouthuy P, Zarkovic N Cells. 2019; 8(8).

PMID: 31366062 PMC: 6721558. DOI: 10.3390/cells8080793.

References
1.
Isakoff M, Bielack S, Meltzer P, Gorlick R . Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015; 33(27):3029-35. PMC: 4979196. DOI: 10.1200/JCO.2014.59.4895. View

2.
Fryer L, Carling D . The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem. 2002; 277(28):25226-32. DOI: 10.1074/jbc.M202489200. View

3.
Yang D, Wang P, Ren X . Apoptosis induced by chamaejasmine in human osteosarcoma cells through p53 pathway. Tumour Biol. 2015; 36(7):5433-9. DOI: 10.1007/s13277-015-3209-5. View

4.
Anderson M . Update on Survival in Osteosarcoma. Orthop Clin North Am. 2015; 47(1):283-92. DOI: 10.1016/j.ocl.2015.08.022. View

5.
Ta H, Dass C, Choong P, Dunstan D . Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009; 28(1-2):247-63. DOI: 10.1007/s10555-009-9186-7. View